Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...

Breast cancer remains the most common invasive cancer diagnosed in women in the United States, accounting for about one in three new female cancers each year. This equates to an expected 310,720 new ...

A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples based on distinct molecular features identified by The ...

Triple-negative breast cancer (TNBC), particularly the luminal androgen receptor (LAR) subtype, presents significant challenges due to its low proliferation rate, high metastatic potential, and ...

A multi-institutional team of scientists has developed a free, publicly accessible resource to aid in classification of patient tumor samples based on distinct molecular features identified by The ...

An FDA advisory committee voted 7-1 to recommend expanding capivasertib use to treat PTEN-deficient metastatic hormone-sensitive prostate cancer, citing improved progression-free survival in a phase ...

Revolutionary imaging technique uncovers metabolic differences in ovarian cancer subtypes, paving the way for early detection and personalized treatment strategies. Study: Metabolic imaging ...

Patients with HS are at an elevated risk for overall and subtype-specific cancers when compared with the general population without HS.

Researchers identified a new subtype of cervical cancer triggered by human papillomavirus, according to a new study published in the journal Oncotarget. For the study, researchers analyzed genomic ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a key enzyme—RNase H2—that helps ...